Supplementary_data_1_APL - Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies

Sasijareonrat, Natthaporn; Jahn, Nikolaus; Ungprasert, Patompong; Owattanapanich, Weerapat

doi:10.25384/SAGE.12571442.v1

Supplementary_data_1_APL.pdf (75.81 kB)

Supplementary_data_1_APL - Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies

journal contribution

posted on 2020-06-26, 12:08 authored by Natthaporn Sasijareonrat, Nikolaus Jahn, Patompong Ungprasert, Weerapat Owattanapanich

Supplementary_data_1_APL for Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies by Natthaporn Sasijareonrat, Nikolaus Jahn, Patompong Ungprasert and Weerapat Owattanapanich in Technology in Cancer Research & Treatment